Cohen Samuel E, Betancourt Jaime, Soo Hoo Guy W
Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
West Los Angeles Veterans Affairs Healthcare Center, VA Greater Los Angeles Healthcare System, Los Angeles, CA 90073, USA.
J Clin Med. 2023 Nov 8;12(22):6977. doi: 10.3390/jcm12226977.
The confirmation of malignant pleural effusions (MPE) requires an invasive procedure. Diagnosis can be difficult and may require repeated thoracentesis or biopsies. Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) can characterize the extent of malignant involvement in areas of increased uptake. Patterns of uptake in the pleura may be sufficient to obviate the need for further invasive procedures.
This is a retrospective review of patients with confirmed malignancy and suspected MPE. Patients who underwent diagnostic thoracentesis with cytology and contemporaneous FDG-PET were identified for analysis. Some underwent confirmatory pleural biopsy. The uptake pattern on FDG-PET underwent blinded review and was categorized based on the pattern of uptake.
One hundred consecutive patients with confirmed malignancy, suspected MPE and corresponding FDG-PET scans were reviewed. MPE was confirmed in 70 patients with positive pleural fluid cytology or tissue pathology. Of the remaining patients, 15 had negative cytopathology, 14 had atypical cells and 1 had reactive cells. Positive uptake on FDG-PET was noted in 76 patients. The concordance of malignant histology and positive FDG-PET occurred in 58 of 76 patients (76%). Combining histologically confirmed MPE with atypical cytology, positive pleural FDG-PET uptake had a positive predictive value of 91% for MPE. An encasement pattern had a 100% PPV for malignancy.
Positive FDG-PET pleural uptake represents an excellent method to identify MPE, especially in patients with an encasement pattern. This may eliminate the need for additional invasive procedures in some patients, even when initial pleural cytology is negative.
恶性胸腔积液(MPE)的确诊需要侵入性操作。诊断可能困难,可能需要重复胸腔穿刺或活检。氟脱氧葡萄糖正电子发射断层扫描(FDG-PET)可以在摄取增加区域表征恶性病变的范围。胸膜的摄取模式可能足以避免进一步的侵入性操作。
这是一项对确诊恶性肿瘤且疑似MPE患者的回顾性研究。确定接受诊断性胸腔穿刺术及同期FDG-PET检查的患者进行分析。部分患者接受了确诊性胸膜活检。对FDG-PET上的摄取模式进行盲法评估,并根据摄取模式进行分类。
回顾了100例确诊恶性肿瘤、疑似MPE并进行了相应FDG-PET扫描的连续患者。70例患者通过胸水细胞学或组织病理学检查确诊为MPE。其余患者中,15例细胞病理学检查为阴性,14例有非典型细胞,1例有反应性细胞。76例患者FDG-PET摄取呈阳性。76例患者中有58例(76%)恶性组织学与FDG-PET阳性结果一致。将组织学确诊的MPE与非典型细胞学结果相结合,胸膜FDG-PET摄取阳性对MPE的阳性预测值为91%。包绕型对恶性肿瘤的阳性预测值为100%。
FDG-PET胸膜摄取阳性是识别MPE的极佳方法,尤其是对于包绕型患者。这可能使部分患者无需进行额外的侵入性操作,即使初始胸膜细胞学检查为阴性。